YOKNEAM, Israel, Jan. 4, 2013 /PRNewswire/ -- Syneron Medical
Ltd. (NASDAQ: ELOS), the leading global aesthetic device company,
announced today that Louis P.
Scafuri, Chief Executive Officer, is scheduled to present at
the 15th Annual Needham Growth Conference in New York City.
(Logo:
http://photos.prnewswire.com/prnh/20120528/535447)
Conference: 15th Annual Needham Growth
Conference
Date:
Tuesday, January 15, 2013
Time:
3:30 p.m. ET
The presentation will be webcast live over the Internet and can
be accessed through the Investor Relations section on Syneron's
website at www.investors.syneron.com. Please go to the website a
few minutes early, as it may be necessary to download audio
software to hear the presentation.
About Syneron Medical Ltd.
Syneron Medical Ltd.
(NASDAQ: ELOS) is the leading global aesthetic device company with
a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through the
treatment of superficial benign vascular and pigmented lesions, and
the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets, services
and supports its products in 90 countries. It has offices in
North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
SOURCE Syneron Medical Ltd.